JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264891

Human GNB4 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GNB4 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 7 bp deletion in exon 2.

View Alternative Names

G protein beta 4 subunit, GBB4_HUMAN, GNB 4, Guanine nucleotide binding protein (G protein) beta polypeptide 4, Guanine nucleotide binding protein beta 4 subunit, Guanine nucleotide binding protein beta polypeptide 4, Guanine nucleotide binding protein beta subunit 4, Guanine nucleotide-binding protein subunit beta-4, Transducin beta chain 4

2 Images
Sanger Sequencing - Human GNB4 knockout HeLa cell line (AB264891)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNB4 knockout HeLa cell line (AB264891)

Allele-2 : 1 bp insertion in exon 2.

Sanger Sequencing - Human GNB4 knockout HeLa cell line (AB264891)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNB4 knockout HeLa cell line (AB264891)

Allele-1 : 7 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 7 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264891-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264891 Human GNB4 knockout HeLa cell line", "number":"AB264891-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264891-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264891 Human GNB4 knockout HeLa cell line", "number":"AB264891-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GNB4
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GNB4 also known as G-protein subunit beta-4 is a component of the heterotrimeric G protein complex which plays a significant role in intracellular signaling. This protein has an approximate molecular weight of 39 kDa. GNB4 is primarily expressed in the brain and also detected in various tissues contributing to its diverse functional roles. As a β-subunit GNB4 forms part of a larger complex that mediates various signal transduction processes by interacting with different receptors on the cell surface.
Biological function summary

The functionality of GNB4 involves interactions within the heterotrimeric G protein complex a critical component of signal transduction pathways. This protein acts as a modulator or adapter in transmembrane signaling systems. GNB4 pairs with gamma subunits to help regulate downstream effector proteins expanding the impact of receptor-binding events initiated by external stimuli. GNB4 influences processes like cell communication and neurotransmission making it an important factor in maintaining cellular functions in neural networks.

Pathways

GNB4 plays essential roles in G-protein coupled receptor (GPCR) signaling and other signaling pathways. In GPCR signaling GNB4 works in concert with alpha and gamma subunits to mediate signal propagation. The complex modulates cyclic AMP levels and activates phospholipase C affecting various cellular responses. GNB4 interacts closely with proteins such as GNAS and ADCY1 forming part of the intricate signaling networks that drive cellular communication and response mechanisms.

Alterations or dysfunction of GNB4 can relate to certain neuropathological conditions. Mutations in the GNB4 gene have been linked to Charcot-Marie-Tooth disease which leads to peripheral neuropathy. This condition correlates with disruptions in GNB4's role in neuron signaling pathways. Additionally GNB4 interacts with proteins like PMP22 which when mutated also associates with this neuropathic disorder highlighting its involvement in these significant health conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com